Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 114 | Longs Won 64/105 60% | Profit Factor 1.8 |
| Profitability | Shorts Won 4/9 44% | Standard Deviation $1,995.69 |
| Average Win $1,004.71 | Best Trade (Nov 20) $10,977.14 | Sharpe Ratio -192.28 |
| Average Loss -$826.8 | Worst Trade (Feb 28) -$7,789.65 | Z-Score -2.03 (99.29%) |
| Commissions $0 | Avg. Trade Length 1m 3w 1d | Expectancy $268.25 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.2% | 2.04% | 15.9% |
| Consecutive Losing Trades | 158 | 142 | 126 | 111 | 95 | 79 | 63 | 47 | 32 | 16 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ARCT Arcturus Therapeutics Holdings Inc. | 7,187.1 | $48,682.88 | $41,325.85 | - | -$7,357.03 | -15.11% | -0.174% |
ATYR Atyr Pharma Inc. | 86,078.12 | $43,246.01 | $42,522.59 | - | -$723.42 | -1.67% | +0.816% |
SMTI Sanara MedTech Inc. | 1,754.2 | $40,283.59 | $46,731.85 | - | $6,448.26 | 16.01% | +3.056% |